Omnicell, Inc.
OMCL
Rank in Stocks
#6518
Omnicell, Inc., together with its subsidiaries, provides healthcare technology... Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Share Price
$37.35
Last synced: 2026-11-09
Market Cap
$1.70B
Change (1 day)
0.03%
Change (1 year)
5.03%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Omnicell, Inc. (OMCL)
Category
Healthcare
EPS for Omnicell, Inc. (OMCL)
EPS as of September 2026 TTM: $0.97
According to Omnicell, Inc.'s latest financial reports, its current EPS (TTM) is $0.97. At the end of 2025 the company had an EPS of $0.04, a decrease compared to its 2024 EPS of $0.27.
EPS history for Omnicell, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.97 | 2,325.00% |
| 2025 | $0.04 | -83.48% |
| 2024 | $0.27 | -160.00% |
| 2023 | $-0.45 | -446.15% |
| 2022 | $0.13 | -92.74% |
| 2021 | $1.79 | 135.53% |
| 2020 | $0.76 | -48.65% |
| 2019 | $1.48 | 54.17% |
| 2018 | $0.96 | 18.52% |
| 2017 | $0.81 | 200.00% |
| 2016 | $0.27 | -68.60% |
| 2015 | $0.86 | 0.00% |
| 2014 | $0.86 | 24.64% |
| 2013 | $0.69 | 40.82% |
| 2012 | $0.49 | 58.06% |
| 2011 | $0.31 | 106.67% |
| 2010 | $0.15 | 1,400.00% |
| 2009 | $0.01 | -97.50% |
| 2008 | $0.40 | -70.37% |
| 2007 | $1.35 | 255.26% |
| 2006 | $0.38 | -574.41% |
| 2005 | $-0.08 | -118.63% |
| 2004 | $0.43 | 34.38% |
| 2003 | $0.32 | -239.13% |
| 2002 | $-0.23 | 109.09% |
| 2001 | $-0.11 | -99.10% |
| 2000 | $-12.20 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.45 | 255.67% |
US
|
|
| $-0.61 | -162.89% |
US
|
|
| $-1.20 | -223.71% |
US
|
|
| $-1.04 | -207.22% |
IL
|
|
| $0.86 | -11.34% |
US
|
Questions about Omnicell, Inc.'s earnings per share (EPS)
What is Omnicell, Inc.'s earnings per share (EPS)?
Omnicell, Inc.'s earnings per share (EPS) over the last twelve months is $0.97, as of Sep 2026.
What was Omnicell, Inc.'s earnings per share (EPS) in 2025?
In 2025, Omnicell, Inc.'s earnings per share (EPS) was $0.04, 85.19% less than in 2024 ($0.27).
How has Omnicell, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Omnicell, Inc.'s earnings per share (EPS) went from $0.76 to $0.04, an average decline of 44.51% a year.
How does Omnicell, Inc.'s earnings per share (EPS) compare with similar companies?
Omnicell, Inc.'s earnings per share (EPS) ($0.97) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Sirona Dental Systems, Inc., with $3.45.